PIN Pharma, Inc.
6Patents
5Active
6Granted
40Portfolio score
Filing activity: Mar 24, 2006 → May 4, 2017 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8530431B2 | Treatment of cancers with immunostimulatory HIV TAT derivative polypeptides | Chemistry; Metallurgy | 4 | Active |
| US9663556B2 | Treatment of cancers with immunostimulatory HIV tat derivative polypeptides | Chemistry; Metallurgy | 1 | Active |
| US10159707B2 | Treatment of cancers with immunostimulatory HIV Tat derivative polypeptides | Chemistry; Metallurgy | 0 | Active |
| US9878001B2 | Immunosuppressive Tat derivative polypeptides | Emerging Cross-Sectional Technologies | 0 | Active |
| US9206239B2 | Treatment of cancers with immunostimulatory HIV Tat derivative polypeptides | Chemistry; Metallurgy | 0 | Active |
| US8323928B2 | Vaccines and immunotherapeutics derived from the human immunodeficiency virus (HIV) transactivator of transcription protein for the treatment and prevention of HIV disease | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.